URYCVE traded at 2.40697 this Friday June 19th, increasing 0.00154 or 0.06 percent since the previous trading session. Looking back, over the last four weeks, URYCVE gained 1.81 percent. Over the last 12 months, its price rose by 2.21 percent. Looking ahead, we forecast URYCVE to be priced at 2.36033 by the end of this quarter and at 2.37948 in one year, according to Trading Economics global macro models projections and analysts expectations.